# D3bio

**Canonical:** https://apis.io/providers/d3bio/  
**Website:** https://www.d3bio.com  
**APIs profiled:** 0

D3bio, also known as D3 Bio, Inc., is a global biotechnology company focused on developing innovative and more efficacious medicines for patients in need worldwide. The company’s mission emphasizes advancing oncology and rare disease treatments through cutting‑edge research and clinical trials, aiming to improve outcomes across diverse patient populations.

## Kin Score — 3.4 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **D3Bio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Biotechnology, Oncology, Rare Disease, Clinical Trials, Healthcare, Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/d3bio/). Scores are computed from the provider's own public artifacts under a published rubric.